PMID19318476: Microarray analysis of early stage serous ovarian cancers...
In bhklab/MetaGxOvarian: Transcriptomic Ovarian Cancer Datasets
Description
Format
Details
Value
Description
Although few women with advanced serous ovarian cancer are cured, detection of the disease at an early stage is associated with a much higher likelihood of survival. We previously used gene expression array analysis to distinguish subsets of advanced cancers based on disease outcome. In the present study, we report on gene expression of early-stage cancers and validate our prognostic model for advanced-stage cancers.Frozen specimens from 39 stage I/II, 42 stage III/IV, and 20 low malignant potential cancers were obtained from four different sites. A linear discriminant model was used to predict survival based upon array data.We validated the late-stage survival model and show that three of the most differentially expressed genes continue to be predictive of outcome. Most early-stage cancers (38 of 39 invasive, 15 of 20 low malignant potential) were classified as long-term survivors (median probabilities 0.97 and 0.86). MAL, the most differentially expressed gene, was further validated at the protein level and found to be an independent predictor of poor survival in an unselected group of advanced serous cancers (P = 0.0004).These data suggest that serous ovarian cancers detected at an early stage generally have a favorable underlying biology similar to advanced-stage cases that are long-term survivors. Conversely, most late-stage ovarian cancers seem to have a more virulent biology. This insight suggests that if screening approaches are to succeed it will be necessary to develop approaches that are able to detect these virulent cancers at an early stage.
Format
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
experimentData(eset):
Experiment data
Experimenter name: Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, Barnett JC, Boren T, Murphy SK, Dressman HK, Marks JR, Lancaster JM.Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res. 2009 Apr 1; 15(7):2448-55.
Laboratory: Berchuck, Lancaster 2009
Contact information:
Title: Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
URL:
PMIDs: 19318476
Abstract: A 241 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133A] Affymetrix Human Genome U133A Array
platform_shorttitle:
Affymetrix HG-U133A
platform_summary:
hgu133a
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL96
warnings:
These samples are a subset of PMID17290060.
version:
2015-09-22 20:20:30
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: 1007_s_at 1053_at ... AFFX-HUMISGF3A/M97935_MB_at
(20967 total)
varLabels: probeset gene EntrezGene.ID best_probe
varMetadata: labelDescription
Details
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
assayData: 20967 features, 42 samples
Platform type:
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
n events median 0.95LCL 0.95UCL
42.00 22.00 2.79 2.30 NA
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
D1462 D1805 D2171 D2208 D2247 D2332 D2432 D2480 D2559 D2560 D2575 D2576 D2611
1 1 1 1 1 1 1 1 1 1 1 1 1
D2629 D2640 D2648 D2736 D2749 D2776 D2792 M1025 M1054 M1055 M120 M1241 M1572
1 1 1 1 1 1 1 1 1 1 1 1 1
M17 M1777 M1891 M2184 M2515 M2807 M3035 M337 M3484 M359 M4161 M444 M503
1 1 1 1 1 1 1 1 1 1 1 1 1
M5668 M5775 M806
1 1 1
sample_type:
tumor
42
histological_type:
ser
42
summarygrade:
high low NA's
24 17 1
summarystage:
early late NA's
2 39 1
tumorstage:
1 2 3 4 NA's
1 1 29 10 1
substage:
a b c NA's
1 1 29 11
grade:
1 2 3 NA's
2 15 24 1
age_at_initial_pathologic_diagnosis:
Min. 1st Qu. Median Mean 3rd Qu. Max. NA's
33.00 55.00 62.00 61.46 70.00 81.00 1
recurrence_status:
norecurrence recurrence
6 36
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max.
30.0 367.5 825.0 1105.0 1050.0 3420.0
vital_status:
deceased living
22 20
debulking:
optimal suboptimal NA's
20 21 1
batch:
2004-03-09 2004-03-16 2004-04-20 2004-05-18 2004-05-21 2004-05-27 2004-06-22
14 3 4 8 6 5 1
2004-06-23
1
uncurated_author_metadata:
Tumor: D1462///NEW.Response: ///SHORT.LONG: NA///AgeDx: 52///DateDx: 11/29/1990///Status: 10/8/91, DOD///Survival..months.: 11///X: 1///STAGE: IIIC///GRADE: 3///Race: b///Debulk: S
1
Tumor: D1805///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 62///DateDx: 3/25/1992///Status: 11/21/92, DOD///Survival..months.: 9///X: 1///STAGE: IV///GRADE: 2///Race: I///Debulk: S
1
Tumor: D2171///NEW.Response: ///SHORT.LONG: NA///AgeDx: 66///DateDx: 10/19/1993///Status: 4/25/03, NED///Survival..months.: 114///X: 0///STAGE: IIIA///GRADE: 3///Race: B///Debulk: O
1
Tumor: D2208///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 62///DateDx: 1/18/1994///Status: 3/22/94, AWD - lost to follow-up///Survival..months.: 2///X: 0///STAGE: IV///GRADE: 3///Race: W///Debulk: S
1
Tumor: D2247///NEW.Response: ///SHORT.LONG: NA///AgeDx: 41///DateDx: 4/21/1994///Status: DOD///Survival..months.: 112///X: 1///STAGE: IIIC///GRADE: 2///Race: B///Debulk: S
1
Tumor: D2332///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 53///DateDx: 12/20/1994///Status: DOD///Survival..months.: 27///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2432///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 61///DateDx: 8/24/1995///Status: DOD///Survival..months.: 35///X: 1///STAGE: IIIC///GRADE: 2///Race: b///Debulk: S
1
Tumor: D2480///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 79///DateDx: 11/15/1995///Status: DOD///Survival..months.: 34///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: D2559///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 46///DateDx: 10/11/1994///Status: DOD///Survival..months.: 5///X: 1///STAGE: IV///GRADE: 3///Race: W///Debulk: O
1
Tumor: D2560///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 5/14/1996///Status: 12/9/03, AWD - despite an elevated CA-125 of 6000, patient is asymptomatic and CT scan shows no definitive measurable disease///Survival..months.: 91///X: 0///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2575///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 71///DateDx: 07/31/96///Status: DOD///Survival..months.: 33///X: 1///STAGE: IV///GRADE: 2///Race: W///Debulk: O
1
Tumor: D2576///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 71///DateDx: 8/13/1996///Status: DOD///Survival..months.: 17///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: D2611///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 56///DateDx: 1/22/1997///Status: DOD///Survival..months.: 2///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: O
1
Tumor: D2629///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 55///DateDx: 2/18/1997///Status: 2/9/00, AWD - on 2/4/00, CA-125 was 6721///Survival..months.: 36///X: 0///STAGE: IV///GRADE: 2///Race: B///Debulk: S
1
Tumor: D2640///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 64///DateDx: 5/27/1997///Status: DOD///Survival..months.: 1///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2648///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 70///DateDx: 6/2/1997///Status: DOD///Survival..months.: 35///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2736///NEW.Response: ///SHORT.LONG: NA///AgeDx: 55///DateDx: 3/10/1998///Status: DOD///Survival..months.: 31///X: 1///STAGE: IIIC///GRADE: 3///Race: b///Debulk: S
1
Tumor: D2749///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 69///DateDx: 4/9/1998///Status: 4/13/00, DOD///Survival..months.: 24///X: 1///STAGE: IIIC///GRADE: 2///Race: w///Debulk: O
1
Tumor: D2776///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 81///DateDx: 5/15/1998///Status: 3/21/99, DOD///Survival..months.: 10///X: 1///STAGE: IIIC///GRADE: 3///Race: w///Debulk: S
1
Tumor: D2792///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 62///DateDx: 7/29/1998///Status: DOD///Survival..months.: 16///X: 1///STAGE: IIIC///GRADE: 3///Race: U///Debulk: S
1
Tumor: M1025///NEW.Response: ///SHORT.LONG: NA///AgeDx: 64///DateDx: 3/21/1996///Status: 9/18/2003, NED///Survival..months.: 90///X: 0///STAGE: IIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M1054///NEW.Response: NR///SHORT.LONG: NA///AgeDx: NA///DateDx: 4/9/1996///Status: 9/15/2004, AWD///Survival..months.: 101///X: 0///STAGE: ///GRADE: NA///Race: ///Debulk:
1
Tumor: M1055///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 67///DateDx: 3/28/1996///Status: 4/8/1997, AWD///Survival..months.: 13///X: 0///STAGE: IIIC///GRADE: 3///Race: Hisp///Debulk: O
1
Tumor: M120///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 51///DateDx: 5/18/1993///Status: 4/10/1996, DOD///Survival..months.: 35///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M1241///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 8/15/1996///Status: 7/2/2004, AWD///Survival..months.: 95///X: 0///STAGE: IV///GRADE: 3///Race: W///Debulk: S
1
Tumor: M1572///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 61///DateDx: 4/15/1997///Status: 2/24/1999, DOD///Survival..months.: 22///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M1777///NEW.Response: ///SHORT.LONG: NA///AgeDx: 72///DateDx: 7/31/1997///Status: 7/23/2004, AWD///Survival..months.: 84///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: M17///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 76///DateDx: 5/29/1992///Status: 10/26/1993, AWD///Survival..months.: 17///X: 0///STAGE: IV///GRADE: 2///Race: W///Debulk: S
1
Tumor: M1891///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 40///DateDx: 9/19/1997///Status: 9/30/1998, AWD///Survival..months.: 12///X: 0///STAGE: IV///GRADE: 1///Race: W///Debulk: S
1
Tumor: M2184///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 57///DateDx: 3/31/1998///Status: 2/7/2001, AWD///Survival..months.: 34///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M2515///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 73///DateDx: 9/10/1998///Status: 7/7/2001, Dead unknown cause///Survival..months.: 34///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: M2807///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 54///DateDx: 1/25/1999///Status: 5/17/1999, NED///Survival..months.: 4///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: M3035///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 63///DateDx: 4/22/1999///Status: 8/25/2001, DOD///Survival..months.: 28///X: 1///STAGE: IV///GRADE: 2///Race: W///Debulk: S
1
Tumor: M337///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 69///DateDx: 7/26/1994///Status: 3/5/2003, NED///Survival..months.: 103///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M3484///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 1/20/2000///Status: 1/22/2001, AWD///Survival..months.: 12///X: 0///STAGE: IIIB///GRADE: 3///Race: W///Debulk: O
1
Tumor: M359///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 71///DateDx: 8/16/1994///Status: 6/02/1997, AWD///Survival..months.: 34///X: 0///STAGE: IIIC///GRADE: 2///Race: W///Debulk: O
1
Tumor: M4161///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 11/8/2000///Status: 3/26/2003, AWD///Survival..months.: 29///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M444///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 33///DateDx: 12/20/1994///Status: 13/3/1995, DOD///Survival..months.: 11///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M503///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 74///DateDx: 1/27/1995///Status: 6/18/1996, AWD///Survival..months.: 17///X: 0///STAGE: IIIC///GRADE: 1///Race: W///Debulk: O
1
Tumor: M5668///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 73///DateDx: 2/13/2003///Status: 6/20/2004, DOD///Survival..months.: 16///X: 1///STAGE: IV///GRADE: 3///Race: W///Debulk: O
1
Tumor: M5775///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 52///DateDx: 3/21/2003///Status: 7/20/2004, AWD///Survival..months.: 16///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M806///NEW.Response: ///SHORT.LONG: NA///AgeDx: 54///DateDx: 10/1/1995///Status: 9/9/2003, NED///Survival..months.: 95///X: 0///STAGE: IC///GRADE: 2///Race: W///Debulk: O
1
Value
An expression set
bhklab/MetaGxOvarian documentation built on Aug. 14, 2021, 1:59 p.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description Format Details Value
Description
Although few women with advanced serous ovarian cancer are cured, detection of the disease at an early stage is associated with a much higher likelihood of survival. We previously used gene expression array analysis to distinguish subsets of advanced cancers based on disease outcome. In the present study, we report on gene expression of early-stage cancers and validate our prognostic model for advanced-stage cancers.Frozen specimens from 39 stage I/II, 42 stage III/IV, and 20 low malignant potential cancers were obtained from four different sites. A linear discriminant model was used to predict survival based upon array data.We validated the late-stage survival model and show that three of the most differentially expressed genes continue to be predictive of outcome. Most early-stage cancers (38 of 39 invasive, 15 of 20 low malignant potential) were classified as long-term survivors (median probabilities 0.97 and 0.86). MAL, the most differentially expressed gene, was further validated at the protein level and found to be an independent predictor of poor survival in an unselected group of advanced serous cancers (P = 0.0004).These data suggest that serous ovarian cancers detected at an early stage generally have a favorable underlying biology similar to advanced-stage cases that are long-term survivors. Conversely, most late-stage ovarian cancers seem to have a more virulent biology. This insight suggests that if screening approaches are to succeed it will be necessary to develop approaches that are able to detect these virulent cancers at an early stage.
Format
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 | experimentData(eset):
Experiment data
Experimenter name: Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, Barnett JC, Boren T, Murphy SK, Dressman HK, Marks JR, Lancaster JM.Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res. 2009 Apr 1; 15(7):2448-55.
Laboratory: Berchuck, Lancaster 2009
Contact information:
Title: Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
URL:
PMIDs: 19318476
Abstract: A 241 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133A] Affymetrix Human Genome U133A Array
platform_shorttitle:
Affymetrix HG-U133A
platform_summary:
hgu133a
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL96
warnings:
These samples are a subset of PMID17290060.
version:
2015-09-22 20:20:30
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: 1007_s_at 1053_at ... AFFX-HUMISGF3A/M97935_MB_at
(20967 total)
varLabels: probeset gene EntrezGene.ID best_probe
varMetadata: labelDescription
|
Details
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 | assayData: 20967 features, 42 samples
Platform type:
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
n events median 0.95LCL 0.95UCL
42.00 22.00 2.79 2.30 NA
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
D1462 D1805 D2171 D2208 D2247 D2332 D2432 D2480 D2559 D2560 D2575 D2576 D2611
1 1 1 1 1 1 1 1 1 1 1 1 1
D2629 D2640 D2648 D2736 D2749 D2776 D2792 M1025 M1054 M1055 M120 M1241 M1572
1 1 1 1 1 1 1 1 1 1 1 1 1
M17 M1777 M1891 M2184 M2515 M2807 M3035 M337 M3484 M359 M4161 M444 M503
1 1 1 1 1 1 1 1 1 1 1 1 1
M5668 M5775 M806
1 1 1
sample_type:
tumor
42
histological_type:
ser
42
summarygrade:
high low NA's
24 17 1
summarystage:
early late NA's
2 39 1
tumorstage:
1 2 3 4 NA's
1 1 29 10 1
substage:
a b c NA's
1 1 29 11
grade:
1 2 3 NA's
2 15 24 1
age_at_initial_pathologic_diagnosis:
Min. 1st Qu. Median Mean 3rd Qu. Max. NA's
33.00 55.00 62.00 61.46 70.00 81.00 1
recurrence_status:
norecurrence recurrence
6 36
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max.
30.0 367.5 825.0 1105.0 1050.0 3420.0
vital_status:
deceased living
22 20
debulking:
optimal suboptimal NA's
20 21 1
batch:
2004-03-09 2004-03-16 2004-04-20 2004-05-18 2004-05-21 2004-05-27 2004-06-22
14 3 4 8 6 5 1
2004-06-23
1
uncurated_author_metadata:
Tumor: D1462///NEW.Response: ///SHORT.LONG: NA///AgeDx: 52///DateDx: 11/29/1990///Status: 10/8/91, DOD///Survival..months.: 11///X: 1///STAGE: IIIC///GRADE: 3///Race: b///Debulk: S
1
Tumor: D1805///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 62///DateDx: 3/25/1992///Status: 11/21/92, DOD///Survival..months.: 9///X: 1///STAGE: IV///GRADE: 2///Race: I///Debulk: S
1
Tumor: D2171///NEW.Response: ///SHORT.LONG: NA///AgeDx: 66///DateDx: 10/19/1993///Status: 4/25/03, NED///Survival..months.: 114///X: 0///STAGE: IIIA///GRADE: 3///Race: B///Debulk: O
1
Tumor: D2208///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 62///DateDx: 1/18/1994///Status: 3/22/94, AWD - lost to follow-up///Survival..months.: 2///X: 0///STAGE: IV///GRADE: 3///Race: W///Debulk: S
1
Tumor: D2247///NEW.Response: ///SHORT.LONG: NA///AgeDx: 41///DateDx: 4/21/1994///Status: DOD///Survival..months.: 112///X: 1///STAGE: IIIC///GRADE: 2///Race: B///Debulk: S
1
Tumor: D2332///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 53///DateDx: 12/20/1994///Status: DOD///Survival..months.: 27///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2432///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 61///DateDx: 8/24/1995///Status: DOD///Survival..months.: 35///X: 1///STAGE: IIIC///GRADE: 2///Race: b///Debulk: S
1
Tumor: D2480///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 79///DateDx: 11/15/1995///Status: DOD///Survival..months.: 34///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: D2559///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 46///DateDx: 10/11/1994///Status: DOD///Survival..months.: 5///X: 1///STAGE: IV///GRADE: 3///Race: W///Debulk: O
1
Tumor: D2560///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 5/14/1996///Status: 12/9/03, AWD - despite an elevated CA-125 of 6000, patient is asymptomatic and CT scan shows no definitive measurable disease///Survival..months.: 91///X: 0///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2575///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 71///DateDx: 07/31/96///Status: DOD///Survival..months.: 33///X: 1///STAGE: IV///GRADE: 2///Race: W///Debulk: O
1
Tumor: D2576///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 71///DateDx: 8/13/1996///Status: DOD///Survival..months.: 17///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: D2611///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 56///DateDx: 1/22/1997///Status: DOD///Survival..months.: 2///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: O
1
Tumor: D2629///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 55///DateDx: 2/18/1997///Status: 2/9/00, AWD - on 2/4/00, CA-125 was 6721///Survival..months.: 36///X: 0///STAGE: IV///GRADE: 2///Race: B///Debulk: S
1
Tumor: D2640///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 64///DateDx: 5/27/1997///Status: DOD///Survival..months.: 1///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2648///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 70///DateDx: 6/2/1997///Status: DOD///Survival..months.: 35///X: 1///STAGE: IIIC///GRADE: 2///Race: W///Debulk: S
1
Tumor: D2736///NEW.Response: ///SHORT.LONG: NA///AgeDx: 55///DateDx: 3/10/1998///Status: DOD///Survival..months.: 31///X: 1///STAGE: IIIC///GRADE: 3///Race: b///Debulk: S
1
Tumor: D2749///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 69///DateDx: 4/9/1998///Status: 4/13/00, DOD///Survival..months.: 24///X: 1///STAGE: IIIC///GRADE: 2///Race: w///Debulk: O
1
Tumor: D2776///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 81///DateDx: 5/15/1998///Status: 3/21/99, DOD///Survival..months.: 10///X: 1///STAGE: IIIC///GRADE: 3///Race: w///Debulk: S
1
Tumor: D2792///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 62///DateDx: 7/29/1998///Status: DOD///Survival..months.: 16///X: 1///STAGE: IIIC///GRADE: 3///Race: U///Debulk: S
1
Tumor: M1025///NEW.Response: ///SHORT.LONG: NA///AgeDx: 64///DateDx: 3/21/1996///Status: 9/18/2003, NED///Survival..months.: 90///X: 0///STAGE: IIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M1054///NEW.Response: NR///SHORT.LONG: NA///AgeDx: NA///DateDx: 4/9/1996///Status: 9/15/2004, AWD///Survival..months.: 101///X: 0///STAGE: ///GRADE: NA///Race: ///Debulk:
1
Tumor: M1055///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 67///DateDx: 3/28/1996///Status: 4/8/1997, AWD///Survival..months.: 13///X: 0///STAGE: IIIC///GRADE: 3///Race: Hisp///Debulk: O
1
Tumor: M120///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 51///DateDx: 5/18/1993///Status: 4/10/1996, DOD///Survival..months.: 35///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M1241///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 8/15/1996///Status: 7/2/2004, AWD///Survival..months.: 95///X: 0///STAGE: IV///GRADE: 3///Race: W///Debulk: S
1
Tumor: M1572///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 61///DateDx: 4/15/1997///Status: 2/24/1999, DOD///Survival..months.: 22///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M1777///NEW.Response: ///SHORT.LONG: NA///AgeDx: 72///DateDx: 7/31/1997///Status: 7/23/2004, AWD///Survival..months.: 84///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: M17///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 76///DateDx: 5/29/1992///Status: 10/26/1993, AWD///Survival..months.: 17///X: 0///STAGE: IV///GRADE: 2///Race: W///Debulk: S
1
Tumor: M1891///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 40///DateDx: 9/19/1997///Status: 9/30/1998, AWD///Survival..months.: 12///X: 0///STAGE: IV///GRADE: 1///Race: W///Debulk: S
1
Tumor: M2184///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 57///DateDx: 3/31/1998///Status: 2/7/2001, AWD///Survival..months.: 34///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M2515///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 73///DateDx: 9/10/1998///Status: 7/7/2001, Dead unknown cause///Survival..months.: 34///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: M2807///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 54///DateDx: 1/25/1999///Status: 5/17/1999, NED///Survival..months.: 4///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: S
1
Tumor: M3035///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 63///DateDx: 4/22/1999///Status: 8/25/2001, DOD///Survival..months.: 28///X: 1///STAGE: IV///GRADE: 2///Race: W///Debulk: S
1
Tumor: M337///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 69///DateDx: 7/26/1994///Status: 3/5/2003, NED///Survival..months.: 103///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M3484///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 1/20/2000///Status: 1/22/2001, AWD///Survival..months.: 12///X: 0///STAGE: IIIB///GRADE: 3///Race: W///Debulk: O
1
Tumor: M359///NEW.Response: NR///SHORT.LONG: NA///AgeDx: 71///DateDx: 8/16/1994///Status: 6/02/1997, AWD///Survival..months.: 34///X: 0///STAGE: IIIC///GRADE: 2///Race: W///Debulk: O
1
Tumor: M4161///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 60///DateDx: 11/8/2000///Status: 3/26/2003, AWD///Survival..months.: 29///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M444///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 33///DateDx: 12/20/1994///Status: 13/3/1995, DOD///Survival..months.: 11///X: 1///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M503///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 74///DateDx: 1/27/1995///Status: 6/18/1996, AWD///Survival..months.: 17///X: 0///STAGE: IIIC///GRADE: 1///Race: W///Debulk: O
1
Tumor: M5668///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 73///DateDx: 2/13/2003///Status: 6/20/2004, DOD///Survival..months.: 16///X: 1///STAGE: IV///GRADE: 3///Race: W///Debulk: O
1
Tumor: M5775///NEW.Response: CR///SHORT.LONG: NA///AgeDx: 52///DateDx: 3/21/2003///Status: 7/20/2004, AWD///Survival..months.: 16///X: 0///STAGE: IIIC///GRADE: 3///Race: W///Debulk: O
1
Tumor: M806///NEW.Response: ///SHORT.LONG: NA///AgeDx: 54///DateDx: 10/1/1995///Status: 9/9/2003, NED///Survival..months.: 95///X: 0///STAGE: IC///GRADE: 2///Race: W///Debulk: O
1
|
Value
An expression set
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.